Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages-Reference-Cited by-同舟云学术

Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages

Published:2020-11 Issue:11 Volume:22 Page:606-616
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Kim Seung Hyeon,Saeidi Soma,Zhong Xiancai^ORCID,Gwak Shin-Young,Muna Ishrat Aklima,Park Sin-Aye,Kim Seong Hoon,Na Hye-Kyung,Joe Yeonsoo,Chung Hun Taeg,Kim Kyoung-Eun,Han Wonshik,Surh Young-Joon

Funder

Global Core Research Center

BK21 Plus Program

National Research Foundation

Ministry of Education, Republic of Korea

Publisher

Elsevier BV

Subject

Cancer Research

Reference49 articles.

1. Recent advances in the treatment of breast cancer;Tong;Front Oncol,2018

2. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer;Du;Ann Intern Med,2003

3. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer;Verma;Breast Cancer Res,2016

4. A history of exploring cancer in context;Maman;Nat Rev Cancer,2018

5. Tumor microenvironment and differential responses to therapy;Hirata;Cold Spring Harbor Perspect Med,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M1 Macrophage-Derived Exosomes Convert TAMs into an Anti-Tumor M1 Phenotype to Inhibit the Progression of Prostate Cancer;J BIOL REG HOMEOS AG;2024

2. Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance;Journal of Clinical Investigation;2023-12-07

3. Tumour-associated macrophages: versatile players in the tumour microenvironment;Frontiers in Cell and Developmental Biology;2023-10-26

4. Macrophages at the interface of the co-evolving cancer ecosystem;Cell;2023-04

5. Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer;Life Sciences;2022-12